Sources | Names Used |
---|---|
GDSC1000 | THZ-2-102-1 |
PharmacoGx | THZ-2-102-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYLK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZNF75A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | TMEM244 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.001 |
mRNA | HRASLS2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
mRNA | TOPORS | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
mRNA | SEC24A | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
mRNA | FBN1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | SAP30 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | VWCE | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | NR3C1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |